BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29670141)

  • 1. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Sci Rep; 2018 Apr; 8(1):6157. PubMed ID: 29670141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA classifier and nomogram for metastasis prediction in colon cancer.
    Goossens-Beumer IJ; Derr RS; Buermans HP; Goeman JJ; Böhringer S; Morreau H; Nitsche U; Janssen KP; van de Velde CJ; Kuppen PJ
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):187-97. PubMed ID: 25315964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
    Caritg O; Navarro A; Moreno I; Martínez-Rodenas F; Cordeiro A; Muñoz C; Ruiz-Martinez M; Santasusagna S; Castellano JJ; Monzó M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.
    Liu C; Eng C; Shen J; Lu Y; Takata Y; Mehdizadeh A; Chang GJ; Rodriguez-Bigas MA; Li Y; Chang P; Mao Y; Hassan MM; Wang F; Li D
    Oncotarget; 2016 Nov; 7(46):76250-76260. PubMed ID: 27788488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.
    Bobowicz M; Skrzypski M; Czapiewski P; Marczyk M; Maciejewska A; Jankowski M; Szulgo-Paczkowska A; Zegarski W; Pawłowski R; Polańska J; Biernat W; Jaśkiewicz J; Jassem J
    Clin Exp Metastasis; 2016 Dec; 33(8):765-773. PubMed ID: 27485175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
    Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
    Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
    Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
    Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
    Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
    Chen W; Yu Q; Chen B; Lu X; Li Q
    Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.
    Hu J; Xu Y; Cai S
    Eur J Med Res; 2015 Dec; 20():95. PubMed ID: 26626874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.